Attenuation of insulin resistance by chronic β2-adrenergic agonist treatment possible muscle specific contributions

Life Sciences

Volumn 69, Issue 5, 2001, Pages 599-611

  Castle, Arthur ^a,b   Yaspelkis III, Benedict B ^a,c   Kuo, Chia Hua ^a,d   Ivy, John L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TAIPEI   (Taiwan)

Author keywords

Diabetes; Glucose transport; GLUT4; Insulin resistance; Muscle hypertropy

Indexed keywords

3 METHYLGLUCOSE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; GLUCOSE TRANSPORTER; INSULIN; TERBUTALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; FAST MUSCLE; FEEDING; GLUCOSE TRANSPORT SYSTEM; HYPERTROPHY; INSULIN RESISTANCE; MUSCLE CELL; MUSCLE MASS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SKELETAL MUSCLE;

3-O-METHYLGLUCOSE; ADRENERGIC BETA-AGONISTS; ANIMALS; BIOLOGICAL TRANSPORT; CLENBUTEROL; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLES; OXIDATION-REDUCTION; RATS; RATS, ZUCKER; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0035933484     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01149-3     Document Type: Article

References (40)

1. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta-adrenoceptor activation
2. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptoragonist(R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2-(3- chlorophenyl) ethyl amino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents
3. Interaction of exercise training and clenbuterol on GLUT4 protein in muscle of obese Zucker rats
4. Increased body-weight gain and body protein in castrated and adrenalectomized rats treated with clenbuterol
5. Influence of clenbuterol on energy balance, thermogenesis and body composition in lean and genetically obese Zucker rats
6. Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle
7. Interaction of aerobic exercise training and clenbuterol: Effects on insulin -resistant muscle
8. Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats
9. Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis
10. Monogenic models of obesity
11. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr)
12. Leptin receptor missense mutation in the fatty Zucker rat
13. Skeletal muscle beta-adrenergic receptors: Variations due to fiber type and training
14. 2 New groups of selective stimulants of adrenergic beta-receptors
15. Pharmacokinetics and metabolic pattern of clenbuterol in the rat
16. Contraction-induced intracellular signals and their relationship to muscle GLUT-4 concentration
17. Glucsoe transport: Locus of muscle insulin resistance in obese Zucker rats
18. Glucose transport into skeletal muscle
19. Citrate synthase
20. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization
21. Glucose transport and cell surface GLUT4 protein in skeletal muscle of the obese Zucker rat
22. Glucose uptake and GLUT4 protein distribution in skeletal muscle of the obese Zucker rat
23. Muscle glucose transport, GLUT-4 content, and degree of exercise training in obese Zucker rats
24. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat
25. Structure and function of the β3-adrenergic receptor
26. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion
27. Effect of beta and beta2 adrenoceptor stimulants infused intrapancreatically on glucagon and insulin secretion
28. Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol
29. Sympathoadrenal system in neuroendocrine control of glucose: Mechanisms involved in the liver, pancreas, and adrenal gland under hemorrhagic and hypoglycemic stress
30. Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue
31. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
32. An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle
33. Localization and characterization of two propranolol resistant (-)[125I]cyanopindolol binding sites in rat skeletal muscle
34. Cyclic AMP accumulation in rat soleus muscle: Stimulation by beta2- but not beta3-adrenoceptors
35. Endurance training, not acute exercise, differentially alters beta-receptors and cyclase in skeletal fiber types
36. Effect of chronic electrical stimulation on GLUT4 protein content in fast-twitch muscle
37. Plasma leptin turnover rates in lean and obese Zucker rats
38. Effect of chronic electrical stimulation and β-GPA diet on GLUT4 protein concentration in rat skeletal muscle
39. Electrical pacing induces adenylyl cyclase in skeletal muscle independent of the beta-adrenergic receptor
40. Cyclic AMP-induced transcriptional repression of the insulin-responsive glucose transporter (Glut4) gene: Identification of a promoter region required for down-regulation of transcription